China pharma projects disrupted by Sino-US tensions
By Andrew Silver SHANGHAI (Reuters) -Drug research and development firms in China including WuXi AppTec and WuXi Biologics are changing ...
Read moreDetailsBy Andrew Silver SHANGHAI (Reuters) -Drug research and development firms in China including WuXi AppTec and WuXi Biologics are changing ...
Read moreDetails
